A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patients (Q42984941)
Jump to navigation
Jump to search
scientific article published on 9 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patients |
scientific article published on 9 October 2012 |
Statements
1 reference
A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patients (English)
1 reference
Jenny Yang
1 reference
Eric J Lawitz
1 reference
John M Hill
1 reference
Thomas Marbury
1 reference
Michael P Demicco
1 reference
William Delaney
1 reference
Lisa Moorehead
1 reference
Anita Mathias
1 reference
Hongmei Mo
1 reference
John G McHutchison
1 reference
Maribel Rodriguez-Torres
1 reference
Stuart C Gordon
1 reference
9 October 2012
1 reference
1 reference
18
1 reference
3
1 reference
311-319
1 reference
Identifiers
1 reference
1 reference